Details for New Drug Application (NDA): 020931

✉ Email this page to a colleague

NDA 020931 describes TIKOSYN, which is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. Additional details are available on the TIKOSYN profile page.

The generic ingredient in TIKOSYN is dofetilide. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dofetilide profile page.

Summary for 020931

Tradename:	TIKOSYN
Applicant:	Pfizer
Ingredient:	dofetilide
Patents:	0

Pharmacology for NDA: 020931

Suppliers and Packaging for NDA: 020931

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TIKOSYN	dofetilide	CAPSULE;ORAL	020931	NDA	Pfizer Laboratories Div Pfizer Inc	0069-5800	0069-5800-43	40 BLISTER PACK in 1 CARTON (0069-5800-43) / 1 CAPSULE in 1 BLISTER PACK
TIKOSYN	dofetilide	CAPSULE;ORAL	020931	NDA	Pfizer Laboratories Div Pfizer Inc	0069-5800	0069-5800-60	60 CAPSULE in 1 BOTTLE (0069-5800-60)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	0.125MG
Approval Date:	Oct 1, 1999	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	0.25MG
Approval Date:	Oct 1, 1999	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	0.5MG
Approval Date:	Oct 1, 1999	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020931

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-003	Oct 1, 1999	⤷ Subscribe	⤷ Subscribe
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-001	Oct 1, 1999	⤷ Subscribe	⤷ Subscribe
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-003	Oct 1, 1999	⤷ Subscribe	⤷ Subscribe
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-002	Oct 1, 1999	⤷ Subscribe	⤷ Subscribe
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-002	Oct 1, 1999	⤷ Subscribe	⤷ Subscribe
Pfizer	TIKOSYN	dofetilide	CAPSULE;ORAL	020931-001	Oct 1, 1999	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.